Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Danimer Scientific, Inc. DNMR OTC

Other OTC • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
38/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$0.90
+157.1%

Danimer Scientific, Inc. (DNMR) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $0.35. It has a SharesGrow Score of 38/100, indicating a weak investment profile with 2 out of 7 criteria passed.

Analyst consensus target is DNMR = $1 (+157.1% upside).

Financials: revenue is $47M, +0.8%/yr average growth. Net income is $155M (loss), growing at -162.4%/yr. Net profit margin is -333% (negative). Gross margin is -57.7% (-81.9 pp trend).

Balance sheet: total debt is $408M against $278M equity (Debt-to-Equity (D/E) ratio 1.47, moderate). Current ratio is 6.87 (strong liquidity). Debt-to-assets is 58.5%. Total assets: $698M.

Analyst outlook: 1 / 4 analysts rate DNMR as buy (25%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 30/100 (Fail), Past 0/100 (Fail), Health 75/100 (Pass), Moat 0/100 (Fail), Future 52/100 (Partial), Income 10/100 (Fail).

$0.90
▲ 157.14% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Danimer Scientific, Inc., the average price target is $0.90, with a high forecast of $1.00, and a low forecast of $0.80.
Highest Price Target
$1.00
Average Price Target
$0.90
Lowest Price Target
$0.80

DNMR SharesGrow Score Overview

53/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 30/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 75/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 52/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — DNMR

✓
VALUE Pass
100/100
DNMR trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Analyst consensus target is $1, implying +185.7% from the current price $0. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
✗
GROWTH Fail
30/100
DNMR: +0.8%/yr revenue is, -162.4%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✓
HEALTH Pass
75/100
Balance sheet DNMR: Debt-to-Equity (D/E) ratio 1.47 (moderate), Current ratio is 6.87 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
~
FUTURE Partial
52/100
Analyst outlook: 1 / 4 analysts rate DNMR as buy (25%). Analyst consensus target is $1 (+185.7% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
DNMR: Net profit margin is -333%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.325-1.85
Volume128.42K
Avg Volume (30D)39.09K
Market Cap$1.06M
Beta (1Y)1.63
Share Statistics
EPS (TTM)-1.52
Shares Outstanding$102M
IPO Date2020-05-28
Employees257
CEORichard N. Altice
Financial Highlights & Ratios
Revenue (TTM)$46.68M
Gross Profit$-26.96M
EBITDA$-96.13M
Net Income$-155.47M
Operating Income$-125.62M
Total Cash$59.17M
Total Debt$408.07M
Net Debt$348.9M
Total Assets$698.13M
Price / Earnings (P/E)-0.2
Price / Sales (P/S)0.02
Analyst Forecast
1Y Price Target$0.90
Target High$1.00
Target Low$0.80
Upside+157.1%
Rating ConsensusHold
Analysts Covering4
Buy 25% Hold 75% Sell 0%
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS2362721001

Price Chart

Track all markets on TradingView
DNMR
Danimer Scientific, Inc. ↗  ·  Other OTC
Basic Materials • Chemicals - Specialty
0.33 52WK RANGE 1.85

People Also View

APD
APD
Air Products and Chemicals, Inc.
$296.63
-0.68%
 SQM
SQM
Sociedad Química y Minera de Chile S.A.
$88.93
+1.48%
 LYB
LYB
LyondellBasell Industries N.V.
$73.25
-2.99%
 DD
DD
DuPont de Nemours, Inc.
$46.68
-1.01%
 IFF
IFF
International Flavors & Fragrances Inc.
$72.59
+1.24%
 WLK
WLK
Westlake Corporation
$117.93
-1.85%
 EMN
EMN
Eastman Chemical Company
$73.79
-0.30%
 CBT
CBT
Cabot Corporation
$74.57
+0.07%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message